Detalhe da pesquisa
1.
Fitusiran reduces bleeding in Factor X-deficient mice.
Blood
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620079
2.
Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models.
Blood
; 141(23): 2891-2900, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928925
3.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Blood
; 141(12): 1457-1468, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564031
4.
Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia.
Circ Res
; 133(10): 826-841, 2023 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883587
5.
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor.
Gene Ther
; 30(3-4): 245-254, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33456057
6.
von Willebrand disease: what does the future hold?
Blood
; 137(17): 2299-2306, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662989
7.
Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc.
Haematologica
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058210
8.
A hemophilia A mouse model for the in vivo assessment of emicizumab function.
Blood
; 136(6): 740-748, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369559
9.
NAADP/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation.
Circ Res
; 127(7): e166-e183, 2020 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588751
10.
Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia.
Blood
; 134(19): 1632-1644, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383642
11.
Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.
Blood
; 133(4): 366-376, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305279
12.
The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.
Blood
; 133(4): 356-365, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30366922
13.
Disrupted filamin A/αIIbß3 interaction induces macrothrombocytopenia by increasing RhoA activity.
Blood
; 133(16): 1778-1788, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30602618
14.
The von Willebrand Factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice.
Haematologica
; 106(3): 819-828, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107335
15.
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation.
Blood
; 132(11): 1193-1197, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064978
16.
A mutation of the human EPHB2 gene leads to a major platelet functional defect.
Blood
; 132(19): 2067-2077, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213874
17.
Shear rate gradients promote a bi-phasic thrombus formation on weak adhesive proteins, such as fibrinogen in a VWF-dependent manner.
Haematologica
; 105(10): 2471-2483, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054087
18.
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA.
Haematologica
; 105(4): 1129-1137, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289204
19.
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
Blood
; 130(23): 2463-2468, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29042366
20.
Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions.
Blood
; 129(17): 2443-2454, 2017 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213380